Advanced Search

Home > Journals > Minerva Biotecnologica > Past Issues > Minerva Biotecnologica 2005 September;17(3) > Minerva Biotecnologica 2005 September;17(3):153-8



A Journal on Biotechnology and Molecular Biology

Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,246

Frequency: Quarterly

ISSN 1120-4826

Online ISSN 1827-160X


Minerva Biotecnologica 2005 September;17(3):153-8


Medicinal plants from Lebanon: effects of essential oils from Pistacia palaestina on proliferation and erythroid differentiation of human leukemic K562 cells

Lampronti I. 1, Saab A. 2, Gambari R. 1, 3

1 Biotechnology Center, University of Ferrara, Ferrara, Italy;
2 Department of Chemistry, Faculty of Sciences II, University of Lebanon, Beirut, Lebanon;
3 ER-GenTech, Department of Biochemistry and Molecular Biology, University of Ferrara, Ferrara, Italy

Aim. Medicinal plants are used in prenatal care, in obstetrics, in gynecology, in respiratory disorders, in skin diseases, in cardiac pathologies, in nervous and muscular disorders, in mental health. In the present paper, we show that essential oil from Pistacia palaestina is able to inhibit the in vitro proliferation of human leukemic K562 cells.
Methods. After producing the essential oils from Pistacia palaestina, the in vitro antiproliferative activity and the induction of erythroid differentiation were assayed.
Results. These results suggest that the antiproliferative activity of Pistacia palaestina is not associated to induction of differentiation. However, when extracts from Pistacia palaestina are added to K562 cells together with suboptimal concentrations of mithramycin, a clear synergic effect was observed.
Conclusion. The results obtained demonstrate a novel antitumor property of Pistacia palaestina extracts, in addition to the previously reported anti-inflammatory, anti-ulcerative and hepatoprotective activities.

language: English

Full text temporarily not available online. Contact us  REPRINTS

top of page